The early cellular pathology of Huntington's disease

Molecular Neurobiology

Volumn 20, Issue 2-3, 1999, Pages 111-124

  Li, Xiao Jiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggregates; Gene expression; Huntingtin; Huntington's disease; Neurodegeneration; Neuropil; Pathogenesis; Polyglutamine

Indexed keywords

CHAPERONIN; DYNACTIN; GLUTAMATE TRANSPORTER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HUNTINGTIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METALLOTHIONEIN; POLYGLUTAMINE; PROTEASOME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECEPTOR;

ARTICLE; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; NEUROPIL; NONHUMAN; PHENOTYPE; TRINUCLEOTIDE REPEAT;

EID: 0033324248     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02742437     Document Type: Article

References (83)

1. 1. Huntington Disease, Collaborative, Research Group (HDCRG). (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
2. 2. Koide, R., Ikeuchi, T., Onodera, O., Tanaka, H., Igarashi, S., Endo, K., et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet. 6, 9-13.
3. 3. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79.
4. 4. Orr, H. T., Chung, M. Y., Banfi, S., Kwiatkowski, T. J., Jr., Servadio, A., Beaudet, A. L., et al. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4, 221-226.
5. 5. Imbert, G., Saudou, F., Yvert, G., Devys, D., Trottier, Y., Garnier, J. M., et al. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet. 14, 285-291.
6. 6. Pulst, S. M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X. N., Lopes-Cendes, I., et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet. 14, 269-276.
7. 7. Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet., 14, 277-284.
8. 7a. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., and et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet. 8, 221-228.
9. 7b. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D.W., Amos, C., et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nature Genet. 15, 62-69.
10. 7c. David, G., Abbas, N., Stevanin, G., Durr, A., Yvert, G., Cancel, G., et al. (1997) Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet. 17, 65-70.
11. 8. MacDonald, M. E., and Gusella, J. F. (1996) Huntington's disease: translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638-643.
12. 9. Andrew, S. E., Goldberg, Y. P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398-403.
13. 10. Duyao, M. P., Taylor, S. A., Buckler, A. J., Ambrose, C. M., Lin, C., Groot, N., et al. (1993) A gene from chromosome 4p16.3 with similarity to a superfamily of transporter proteins. Hum. Mol. Genet. 2, 673-676.
14. 11. Stine, O. C., Pleasant, N., Franz, M. L., Abbott, M. H., Folstein, S. E., and Ross, C. A. (1993) Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2, 1547-1549.
15. 12. Folstein, S. E. (1989) A Disorder of Families. The Johns Hopkins University Press, Baltimore, MD.
16. 13. Harper, P. S. (1991) Huntington's Disease. W. B. Saunders, London, UK.
17. 14. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P., Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol Exp. Neurol. 44, 559-577.
18. 15. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
19. 16. Ordway, J. M., Tallaksen-Greene, S., Gutekunst, C. A., Bernstein, E. M., Cearley, J. A., Wiener, H. W., et al. (1997) Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-763.
20. 17. Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., Jr., Miller, G., and Tagle, D. A. (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nature Genet. 20, 198-202.
21. 18. Hodgson, J. G., Agopyan, N., Gutekunst, C. A., Leavitt, B. R., LePiane, F., Singaraja, R., et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181-192.
22. 19. Schilling, G., Becher, M. W., Sharp, A. H., Jinnah, H. A., Duan, K., Kotzuk, J. A., et al. (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407.
23. 20. Cooper, J. K., Schilling, G., Peters, M. F., Herring, W. J., Sharp, A. H., Kaminsky, Z., et al. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol Genet. 7, 783-790.
24. 21. Li, S. H., and Li, X. J. (1998) Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777-782.
25. 22. Martindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18, 150-154.
26. 23. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
27. 24. Becher, M. W., Kotzuk, J. A., Pavlakis, G. N., Sharp, A. H., Davies, S. W., Bates, G. P., et al. (1998) Intranuclear neuronal inclusions in Huntington's disease and Dentatorubural and Pallidoluysian Atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4, 387-397.
28. 25. Igarashi, S., Koide, R., Shimohata, T., Yamada, M., Hayashi, Y., Takano, H., et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111-117.
29. 26. Butler, R., Leigh, P. N., McPhaul, M. J., and Gallo, J. M. (1998) Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7, 121-127.
30. 27. Merry, D. E., Kobayashi Y, Bailey, C. K., Taye, A. A., and Fischbeck K. H. (1998) Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet 7, 693-701.
31. 28. Matilla, A., Koshy, B. T., Cummings, C. J., Isobe, T., Orr, H. T., and Zoghbi, H. Y. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389, 974-978.
32. 29. Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., et al. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974.
33. 30. Koyano, S., Uchihara, T., Fujigasaki, H., Nakamura, A., Yagishita, S., and Iwabuchi, K. (1999) Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci. Lett. 273, 117-120.
34. 31. Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., and Kakizuka, A. (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196-202.
35. 32. Paulson, H. L., Perez, M. K., Trottier, Y., Trojanowski, J. Q., Subramony, S. H., Das, S. S., et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344.
36. 33. Ishikawa, K., Fujigasaki, H., Saegusa, H., Ohwada, K., Fujita, T., Iwamoto, H., et al. (1999) Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 8, 1185-1193.
37. 34. Holmberg, M., Duyckaerts, C., Durr, A., Cancel, G., Gourfinkel-An, I., Damier, P., et al. (1998) Spinocerebellar ataxia type 7 (SCAT): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913-918.
38. 35. Hackam, A. S., Singaraja, R., Zhang, T., Gan, L., and Hayden, M. R. (1999) In vitro evidence for both the nucleus and cytoplasmas subcellular sites of pathogenesis in Huntington's disease. Hum. Mol. Genet. 8, 25-33.
39. 36. Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA 1 transgenic mice [see comments]. Cell 95, 41-53.
40. 37. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
41. 38. Kim, M., Lee, H. S., LaForet, G., McIntyre, C., Martin, E. J., Chang, P., et al. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964-973.
42. 39. Gutekunst, C. A., Li, S. H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., and Li, X. J. (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522-2534.
43. 40. Clark, H. B., Burright, E. N., Yunis, W. S., Larson, S., Wilcox, C., Hartman, B., et al. (1997) Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 17, 7385-7395.
44. 41. Faber, P. W., Alter, J. R., MacDonald, M. E., and Hart, A. C. (1999) Polyglutamine-mediated dysfunction and apoptotic death of a caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. USA 96, 179-184.
45. 42. Li, S. H., Cheng, A. L., Li, H., and Li, X. J. (1999) Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J. Neurosci. 19, 5159-5172.
46. 43. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., and Bates, G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
47. 44. Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., et al. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257.
48. 45. Davies, S. W., Turmaine, M., Cozens, B. A., Raza, A. S., Mahal, A., Mangiarini, L., and Bates, G. P. (1999) From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354, 981-989.
49. 46. White, J. K., Auerbach, W., Duyao, M. P., Vonsattel, J. P., Gusella, J. F., Joyner, A. L., and MacDonald, M. E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17, 404-410.
50. 47. Shelbourne, P. F., Killeen, N., Hevner, R. F., Johnston, H. M., Tecott, L., Lewandoski, M., et al. (1999) A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 8, 763-774.
51. 48. Meyers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B., and Bird, E. D. (1998) Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 38, 341-347.
52. 49. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
53. 50. Li, H., Li, S. H., Cheng, A. L., Mangiarini, L., Bates, G. P., and Li, X. J. (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet. 8, 1227-1236.
54. 51. Wheeler, V. C., White, J. K., Gutekunst, C. A., Vrbanac, V., Weaver, M., Li, X. J., Li, S. H., Yi, H., Vonsattel, J. P., Gusella, J. F., Hersch, S., Auerbach, W., Joyner, A. L., and MacDonald, M. E. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 9, 503-513.
55. 52. Li, H., Li, S. H., Johnston, H., Shelbourne, P. F., and Li, X. J. (2000). N-terminal fragments of mutant huntingtin: selective accumulation in striatal neurons and synaptic toxicity. Nature Genet., in press.
56. 53. Yao, R., Yoshihara, M., and Osada, H. (1997) Specific activation of a c-Jun NH2-terminal kinase isoform and induction of neurite outgrowth in PC-12 cells by staurosporine. J. Biol. Chem. 272, 18261-18266.
57. 54. Ferrante, R. J., Kowall, N. W., and Richardson, E. P., Jr. (1991) Proliferarive and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J. Neurosci. 11, 3877-3887.
58. 55. Sotrel, A., Williams, R. S., Kaufmann, W. E., and Myers, R. H. (1993) Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 43, 2088-2096.
59. 56. Graveland, G. A., Williams, R. S., and DiFiglia, M. (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
60. 57. Perez, M. K., Paulson, H. L., Pendse, S. J., Saionz, S. J., Bonini, N. M., and Pittman, R. N. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143, 1457-1470.
61. 58. Perutz, M. F., Johnson, T., Suzuki, M., and Finch, J. T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Scei. USA 91, 5355-5358.
62. 59. Kahlem, P., Terre, C., Green, H., and Djian, P. (1996) Peptides containing glu famine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA 93, 14580-14585.
63. 60. Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., and Zoghbi, H. Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19, 148-154.
64. 61. Chai, Y., Koppenhafer, S. L., Shoesmith, S. J., Perez, M. K., and Paulson, H. L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673-682.
65. 62. Li, X. J., Li, S. H., Sharp, A. H., Nucifora, F. C., Jr., Schilling, G., Lanahan, A., et al. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
66. 63. Burke, J. R., Enghild, J. J., Martin, M. E., Jou, Y S., Myers, R. M., Roses, A. D., et al. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347-350.
67. 64. Bao, J., Sharp, A. H., Wagster, M. V., Becher, M., Schilling, G., Ross, C. A., Dawson, V. L., and Dawson, T. M. (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. USA 93, 5037-5042.
68. 65. Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., et al. (1998) SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell 427-436.
69. 66. Cha, J. H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., et al. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl. Acad. Sci. USA 95, 6480-6485.
70. 67. Li, S. H., Gutekunst, C. A., Hersch, S. M., and Li, X. J. (1998) Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 18, 1261-1269.
71. 68. Karin, M. (1985) Metallothioneins: proteins in search of function. Cell 41, 9-10.
72. 69. Schwarz, M. A., Lazo, J. S., Yalowich, J. C., Allen W. P., Whitmore, M., Bergonia, H. A., et al. (1995) Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA 92, 4452-4456.
73. 70. Courey, A. J., and Tjian, R. (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898.
74. 71. Courey, A. J., Holtzman, D. A., Jackson, S. P., and Tjian, R. (1989) Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59, 827-836.
75. 72. Gerber, H. P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S., and Schaffner, W. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808-811.
76. 73. Huang, C. C., Faber, P. W., Persichetti, F., Mittal, V., Vonsattel, J. P., MacDonald, M. E., and Gusella, J. F. (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol. Genet. 24, 217-233.
77. 74. Beal, M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurpl. 31, 119-130.
78. 75. Engelender, S., Sharp, A. H., Colomer, V., Tokito, M. K., Lanahan, A., Worley, P., et al. (1997) Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6, 2205-2212.
79. 76. Usdin, M. T., Shelbourne, P. F., Myers, R. M., and Madison, D. V. (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8, 839-846.
80. 77. Albin, R. L. and Greenamyre, J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42, 733-738.
81. 78. Selemon, L. D., and Goldman-Rakic, P. S. (1985) Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J. Neurosci. 5, 776-794.
82. 79. Calabresi, P., Pisani, A., Mercuri, N. B., and Bernardi, G. (1996) The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosoci. 19, 19-24.
83. 80. Reddy, P. H., Charles, V., Williams, M., Miller, G., Whetsell, W. O., Jr., and Tagle, D. A. (1999) Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354, 1035-1045.